UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000838
Receipt number R000001003
Scientific Title Multi-centric randomized open-label comparative study for influence of bisphosphonate on fracture healing in patients with spinal compression fractures or femoral neck fractures
Date of disclosure of the study information 2007/10/01
Last modified on 2012/10/01 19:12:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multi-centric randomized open-label comparative study for influence of bisphosphonate on fracture healing in patients with spinal compression fractures or femoral neck fractures

Acronym

Influence of bisphosphonate on spinal compression fractures or femoral neck fractures

Scientific Title

Multi-centric randomized open-label comparative study for influence of bisphosphonate on fracture healing in patients with spinal compression fractures or femoral neck fractures

Scientific Title:Acronym

Influence of bisphosphonate on spinal compression fractures or femoral neck fractures

Region

Japan


Condition

Condition

Osteoporotic spinal compression fractures and femoral neck fractures

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the difference of the influence of sodium risedronate hydrate on fracture healing in patients with spinal compression fracture or femoral neck fracture depending on the starting point of the medication.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fracture healing is assessed with X ray film and computed tomograhy, and QOL is assessed with questionnaires.

Key secondary outcomes

Bone mineral density, visual analogue scale and bone markers are measured.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Sodium risedronate hydrate was given from 1 week after injury or surgery in group A.

Interventions/Control_2

Sodium risedronate hydrate was given from 3 months after injury or surgery in group B.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Inclusion criteria are primary osteoporosis patients with the age of 65 to 90 years old, osteoporotic spinal compression fractures, and osteoporotic femoral neck fractures.

Key exclusion criteria

Exclusion criteria are patients treated with bisphosphonate within 3 months, fractures resulted from high energy trauma, patients contraindicant to bisphosphonate, and patients judged inadequate to include this study by doctors.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoru Ozeki

Organization

Dokkyo Medical University Koshigaya Hospital

Division name

Department of Orthopaedic Surgery

Zip code


Address

2-1-50 Minami-Koshigaya, Koshigaya, Saitama, Japan

TEL

048-965-1111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Takahiro Iida

Organization

Dokkyo Medical University Koshigaya Hospital

Division name

Department of Orthopaedic Surgery

Zip code


Address

2-1-50 Minami-Koshigaya, Koshigaya, Saitama, Japan

TEL

048-965-1111

Homepage URL


Email

takiida@dokkyomed.ac.jp


Sponsor or person

Institute

Department of Orthopaedic Surgery, Dokkyo Medical University Koshigaya Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Orthopaedic Surgery, Dokkyo Medical University Koshigaya Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 09 Month 18 Day

Date of IRB


Anticipated trial start date

2007 Year 10 Month 01 Day

Last follow-up date

2012 Year 04 Month 01 Day

Date of closure to data entry

2012 Year 04 Month 01 Day

Date trial data considered complete

2012 Year 04 Month 01 Day

Date analysis concluded

2012 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 09 Month 30 Day

Last modified on

2012 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001003